Supernus Pharmaceuticals, Inc

(NASDAQ:SUPN)

Latest On Supernus Pharmaceuticals, Inc (SUPN):

Date/Time Type Description Signal Details
2023-05-10 07:37 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 18:39 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55, revenue of $153.8M beats by $14.78MN/A
2023-05-09 04:36 ESTNewsSupernus Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-04 20:51 ESTNewsSupernus Pharmaceuticals pays out $402M senior convertible notesN/A
2023-03-01 01:40 ESTNewsSupernus Pharmaceuticals reports Q4 results, sees FY 2023 revenue in-lineN/A
2023-03-01 01:40 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q4 2022 Earnings Call TranscriptN/A
2023-02-27 20:04 ESTNewsSupernus Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-15 02:54 ESTNewsSupernus secures $150M line of credit from UBS Bank USAN/A
2023-02-10 18:44 ESTNewsSupernus: Earnings YearningsN/A
2022-11-30 06:36 ESTNewsSupernus Pharmaceuticals: Shares Could Get CheapN/A
2022-11-08 19:34 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.03 misses by $0.33, revenue of $177.35M beats by $4.87MN/A
2022-11-08 19:34 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 01:06 ESTNewsSupernus Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-10-10 17:31 ESTNewsSupernus stock falls 12.6% after FDA declines to approve Parkinson’s disease treatmentN/A
2022-09-10 04:18 ESTNewsSupernus Pharmaceuticals (SUPN) Investor Presentation - SlideshowN/A
2022-08-20 11:47 ESTNewsSupernus Pharmaceuticals: Deep Expertise In CNS, Eyes On Qelbree Launch And Parkinson PortfolioN/A
2022-08-07 11:02 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 17:16 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.14 misses by $0.15, revenue of $170.05M beats by $5.82MN/A
2022-08-04 02:17 ESTNewsSupernus Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-29 04:48 ESTNewsSupernus: A Work In ProgressN/A
2022-05-10 14:29 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 17:15 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.43 misses by $0.02, revenue of $152.51M beats by $2.04MN/A
2022-05-07 08:04 ESTNewsSupernus Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-05-02 09:21 ESTNewsSupernus rises on FDA label expansion of ADHD therapyN/A
2022-04-13 23:14 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.04 misses by $0.20, revenue of $159.05M in-lineN/A
2022-04-04 23:36 ESTNewsSupernus Pharmaceuticals drops 2.7% on 2022 guidanceN/A
2022-03-29 12:05 ESTNewsSupernus: New BeginningsN/A
2022-03-17 23:24 ESTNewsSupernus Pharmaceuticals notifies Nasdaq regarding non-compliance with listing ruleN/A
2022-03-01 13:25 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 00:52 ESTNewsSupernus Pharmaceuticals Q4 2021 Earnings PreviewN/A
2021-12-02 05:34 ESTNewsSupernus Pharma resumed Buy at Jefferies citing Adamas acquisitionN/A
2021-11-27 01:18 ESTNewsJasper more than doubles while M&A headlines weekly healthcare performersN/A
2021-11-04 16:57 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 19:31 ESTNewsSupernus Pharmaceuticals EPS beats by $0.17, beats on revenue; updates full year guidanceN/A
2021-11-03 19:30 ESTNewsSupernus up 10% following 2021 earnings guidance boost, Q3 beatN/A
2021-11-02 23:54 ESTNewsSupernus Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-27 03:49 ESTNewsAdamas Pharmaceuticals: An Acceptable Buyout At The Perfect TimeN/A
2021-10-11 18:00 ESTNewsSupernus to acquire Adamas in a deal worth up to $850 millionN/A
2021-10-11 17:59 ESTNewsAs Supernus acquires Adamas, other Parkinson's players mixed on the dayN/A
2021-09-03 02:57 ESTNewsFDA accepts for review Supernus' Qelbree sNDA for ADHD in adultsN/A
2021-08-26 01:08 ESTNewsSupernus: Well Prepared For Upcoming ChallengesN/A
2021-08-05 13:54 ESTNewsSupernus Pharmaceuticals EPS beats by $0.23, beats on revenueN/A
2021-08-05 13:53 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-03 19:03 ESTNewsSupernus Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-07-30 21:28 ESTNewsSupernus Pharma appoints Opgen executive as new CFON/A
2021-07-22 02:11 ESTNewsSupernus Pharma inks supply agreement with Bachem for key ingredient in ADHD drugN/A
2021-05-05 23:52 ESTNewsSupernus Pharmaceuticals EPS misses by $0.11, beats on revenue; reaffirms guidanceN/A
2021-05-05 23:51 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2021 Results - Earnings Call TranscriptN/A
2021-05-05 03:39 ESTNewsSupernus Pharmaceuticals Q1 2021 Earnings PreviewN/A
2021-04-13 20:31 ESTNewsIRhythm extends losses as more downgrades pile up, Aphria cut to neutral after earnings miss; and more in today’s analyst actionN/A

About Supernus Pharmaceuticals, Inc (SUPN):

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise APOKYN, a product indicated for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO, a product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults. In addition, its product candidates include SPN-812, which has completed Phase III clinical trials that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-830, a late-stage drug/device combination product candidate for the prevention of off episodes in PD; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; and SPN-820, a novel product candidate in Phase I clinical trials for treatment resistant depression. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development and option agreement with Navitor Pharmaceuticals, Inc. to conduct a Phase II clinical program for NV-5138 in treatment-resistant depression. The company was founded in 2005 and is headquartered in Rockville, Maryland.

SUPN Quotes by TradingView

See Advanced Chart

General

  • Name Supernus Pharmaceuticals, Inc
  • Symbol SUPN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 563
  • Fiscal Year EndDecember
  • IPO Date2012-05-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.supernus.com
View More

Valuation

  • Trailing PE 11.12
  • Forward PE 20.16
  • Price/Sales (Trailing 12 Mt.) 2.76
  • Price/Book (Most Recent Quarter) 1.9
  • Enterprise Value Revenue 2.66
  • Enterprise Value EBITDA 6.58
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.02
  • Next Year EPS Estimate $1.24
  • Next Quarter EPS Estimate $0.40
  • Profit Margin 24%
  • Operating Margin 36%
  • Return on Assets 9%
  • Return on Equity 19%
  • Revenue 520.4 million
  • Earnings Per Share $2.36
  • Revenue Per Share $9.89
  • Gross Profit 467.94 million
  • Quarterly Earnings Growth 42.9%
View More

Highlights

  • Market Capitalization 1.39 billion
  • EBITDA 206.24 million
  • PE Ratio 369.82
  • PEG Ratio 1.47
  • Analyst Target Price $30.75
  • Book Value Per Share $14.09
View More

Share Statistics

  • Shares Outstanding 52.92 million
  • Shares Float 47.91 million
  • % Held by Insiders 361%
  • % Held by Institutions 101.46%
  • Shares Short 7.47 million
  • Shares Short Prior Month 7.15 million
  • Short Ratio 14.42
  • Short % of Float 21%
  • Short % of Shares Outstanding 14%
View More

Technicals

  • Beta 1.29
  • 52 Week High $31.99
  • 52 Week Low $15.58
  • 50 Day Moving Average 28.34
  • 200 Day Moving Average 24.03
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Supernus Pharmaceuticals, Inc (SUPN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Supernus Pharmaceuticals, Inc (SUPN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.57$0.4916.33%
2020-09-302020-11-03$155.14 million$0.74$0.27170.76%
2020-06-302020-08-17$126.73 million$0.65$0.4254.76%
2020-03-312020-05-05$N/A$0.40$0.2653.85%
2019-12-312020-02-25$100.45 million$0.62$0.595.8%
2019-09-302019-11-05$102.14 million$0.54$0.59-8.47%
2019-06-302019-08-06$104.7 million$0.61$0.601.24%
2019-03-312019-05-07$85.47 million$0.34$0.47-26.88%
2018-12-312019-02-26$115.93 million$0.48$0.2967.19%
2018-09-302018-11-06$103 million$0.52$0.4222.93%
2018-06-302018-08-07$99.54 million$0.57$0.4526.67%
2018-03-312018-05-08$90.43 million$0.49$0.3251.94%
2017-12-312018-02-27$88.44 million$0.26$0.28-7.6%
2017-09-302017-11-06$80.4 million$0.30$0.286.71%
2017-06-302017-08-02$75.83 million$0.33$0.2436.5%
2017-03-312017-05-09$57.58 million$0.19$0.25-24%
2016-12-312017-01-20$62.37 million$0.37$0.347.19%
2016-09-302016-09-30$56.81 million$1.18$0.34247.06%
2016-06-302016-08-02$51.63 million$0.18$0.1336.67%
2016-03-312016-05-04$44.19 million$0.10$0.0913.8%
2015-12-312016-03-02$43.69 million$0.14$0.06128.83%
2015-09-302015-11-03$39.36 million$0.08$0.02300%
2015-06-302015-08-04$35.68 million$0.03$0.0250%
2015-03-312015-05-05$28.74 million$0.02-$0.01300%
2014-12-312015-03-10$31.24 million$0.10-$0.12183.33%
2014-09-302014-11-11$52.49 million$0.39$0.368.33%
2014-06-302014-08-11$29.68 million$0.08-$0.15153.33%
2014-03-312014-05-12$9.08 million-$0.35-$0.4114.63%
2013-12-312014-03-12$10.34 million-$0.39-$0.5529.09%
2013-09-302013-11-12$1.26 million-$0.64-$0.674.48%
2013-06-302013-08-13$281000-$0.57-$0.6512.31%
2013-03-312013-05-13$147000-$0.60-$0.7115.49%
2012-12-312013-03-14$1.09 million-$0.51-$0.7128.17%
2012-09-302012-11-07$92000-$0.55-$0.6211.29%
2012-06-302012-08-10$91000-$0.61-$0.48-27.08%
2012-03-312012-06-07$208000-$0.42

Supernus Pharmaceuticals, Inc (SUPN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Supernus Pharmaceuticals, Inc (SUPN) Chart:

Supernus Pharmaceuticals, Inc (SUPN) News:

Below you will find a list of latest news for Supernus Pharmaceuticals, Inc (SUPN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Supernus Pharmaceuticals, Inc (SUPN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-03-20200CALL0 0183.97TRUE00
2026-03-20250CALL0 0142.46TRUE00
2026-03-20260CALL0 0120.39TRUE00
2026-03-20270CALL0 0113.63TRUE00
2026-03-20280CALL0 0107.11TRUE00
2026-03-20290CALL0 0131.39TRUE00
2026-03-203020.81CALL0 5124.67TRUE00
2026-03-20310CALL0 0118.18TRUE00
2026-03-20320CALL0 0105.39TRUE00
2026-03-20330CALL0 00TRUE00
2026-03-20340CALL0 00TRUE00
2026-03-20350CALL0 00TRUE00
2026-03-20360CALL0 0104.58TRUE00
2026-03-20374.7CALL0 298.48TRUE00
2026-03-20387.74CALL0 598.3TRUE00
2026-03-20390CALL0 092.23TRUE00
2026-03-204010.2CALL0 6086.27TRUE00
2026-03-20410CALL0 089.26TRUE00
2026-03-20420CALL0 086.94TRUE00
2026-03-20430CALL0 084.18TRUE00
2026-03-20440CALL0 059.01TRUE00
2026-03-20457.2CALL0 1063.36TRUE00
2026-03-20467.15CALL0 462.31TRUE00
2026-03-20475.6CALL0 1584.3TRUE00
2026-03-20484.95CALL0 579.13TRUE00
2026-03-20493.7CALL0 162.85TRUE00
2026-03-20504.62CALL760 11748.45TRUE1.120.32
2026-03-20553.4CALL524 1274.9FALSE1.81.13
2026-03-20600.55CALL114 7188.84FALSE0.550
2026-03-20650.95CALL707 83976.25FALSE0.950
2026-03-20700CALL0 0133.8FALSE00
2026-03-20750CALL0 0143.04FALSE00
2026-03-20200.04PUT0 2364.71FALSE00
2026-03-20250PUT0 0293.52FALSE00
2026-03-20260PUT0 0281.2FALSE00
2026-03-20270PUT0 0269.38FALSE00
2026-03-20280PUT0 0258.02FALSE00
2026-03-20290PUT0 0247.07FALSE00
2026-03-20300PUT0 0236.5FALSE00
2026-03-20310PUT0 0226.28FALSE00
2026-03-20320PUT0 0216.38FALSE00
2026-03-20330PUT0 0125.89FALSE00
2026-03-20340.1PUT2 091.1FALSE0.10
2026-03-20351PUT0 2190.03FALSE00
2026-03-20360PUT0 0182.75FALSE00
2026-03-20372.05PUT0 1175.56FALSE00
2026-03-20381.05PUT0 1168.45FALSE00
2026-03-20390PUT0 0164.32FALSE00
2026-03-20400PUT0 0157.23FALSE00
2026-03-20412.25PUT0 1151.54FALSE00
2026-03-20422.7PUT0 10145.79FALSE00
2026-03-20431PUT0 13105.02FALSE00
2026-03-20442.55PUT0 183.48FALSE00
2026-03-20451.2PUT3 1182.02FALSE1.20
2026-03-20460PUT0 0127.61FALSE00
2026-03-20470PUT0 0148.88FALSE00
2026-03-20480PUT0 0102.13FALSE00
2026-03-20492.55PUT0 186.6FALSE00
2026-03-20502.5PUT44 70075.42FALSE-0.65-0.21
2026-03-20555.68PUT0 577.11TRUE00
2026-03-20600PUT0 085.34TRUE00
2026-03-20650PUT0 087.28TRUE00
2026-03-20700PUT0 080.73TRUE00
2026-03-20750PUT0 070.49TRUE00
2026-04-17350CALL0 045.24TRUE00
2026-04-17400CALL0 054.83TRUE00
2026-04-17450CALL0 059.41TRUE00
2026-04-17500CALL0 050.53TRUE00
2026-04-17553.9CALL6 056.31FALSE3.90
2026-04-17600CALL0 043.94FALSE00
2026-04-17650CALL0 085.76FALSE00
2026-04-17700CALL0 096.29FALSE00
2026-04-17750CALL0 0100.73FALSE00
2026-04-17350PUT0 0128.51FALSE00
2026-04-17400PUT0 0100.64FALSE00
2026-04-17450PUT0 0114.61FALSE00
2026-04-17500PUT0 061.5FALSE00
2026-04-17550PUT0 057.74TRUE00
2026-04-17600PUT0 063.37TRUE00
2026-04-17650PUT0 056.9TRUE00
2026-04-17700PUT0 058.82TRUE00
2026-04-17750PUT0 067.67TRUE00
2026-06-18250CALL0 068.45TRUE00
2026-06-18300CALL0 056.65TRUE00
2026-06-18350CALL0 051.18TRUE00
2026-06-184014.17CALL0 153.55TRUE00
2026-06-18410CALL0 050.21TRUE00
2026-06-18420CALL0 052.7TRUE00
2026-06-18430CALL0 050.59TRUE00
2026-06-18440CALL0 052.68TRUE00
2026-06-18450CALL0 055.3TRUE00
2026-06-18460CALL0 056.31TRUE00
2026-06-18476.4CALL0 257.47TRUE00
2026-06-18480CALL0 054.92TRUE00
2026-06-18497.4CALL0 154.63TRUE00
2026-06-18505.2CALL0 655.03TRUE00
2026-06-18555.2CALL0 1246.53FALSE00
2026-06-18604CALL5 8152.6FALSE40
2026-06-18652CALL0 1547.07FALSE00
2026-06-18701.75CALL0 265.72FALSE00
2026-06-18750.75CALL0 568.91FALSE00
2026-06-18800.65CALL0 473.36FALSE00
2026-06-18250PUT0 0135.87FALSE00
2026-06-18300PUT0 0110.63FALSE00
2026-06-18350PUT0 094.55FALSE00
2026-06-18402.1PUT0 076.62FALSE00
2026-06-18412.25PUT0 275.13FALSE00
2026-06-18420PUT0 074.7FALSE00
2026-06-18430PUT0 076.28FALSE00
2026-06-18444.2PUT0 1072.18FALSE00
2026-06-18454.5PUT0 754.44FALSE00
2026-06-18460PUT0 052.69FALSE00
2026-06-18474.4PUT0 151.57FALSE00
2026-06-18480PUT0 054.65FALSE00
2026-06-18490PUT0 055.15FALSE00
2026-06-18500PUT0 055.61FALSE00
2026-06-18559.7PUT0 150.91TRUE00
2026-06-186011.59PUT0 552.08TRUE00
2026-06-18650PUT0 048.38TRUE00
2026-06-18700PUT0 047.15TRUE00
2026-06-18750PUT0 046.53TRUE00
2026-06-18800PUT0 00TRUE00
2026-09-18250CALL0 079.42TRUE00
2026-09-18300CALL0 068.04TRUE00
2026-09-18350CALL0 060.61TRUE00
2026-09-18400CALL0 057.64TRUE00
2026-09-18430CALL0 057.1TRUE00
2026-09-18440CALL0 057.97TRUE00
2026-09-18450CALL0 056.29TRUE00
2026-09-18460CALL0 056.46TRUE00
2026-09-18470CALL0 056.47TRUE00
2026-09-18480CALL0 056.69TRUE00
2026-09-18490CALL0 056.43TRUE00
2026-09-18500CALL0 056.39TRUE00
2026-09-18550CALL0 053.86FALSE00
2026-09-18605CALL1 357FALSE50
2026-09-18653.7CALL0 149.08FALSE00
2026-09-18702CALL0 258.39FALSE00
2026-09-18752CALL0 159.02FALSE00
2026-09-18250PUT0 0141.16FALSE00
2026-09-18300.95PUT0 1115.56FALSE00
2026-09-18350PUT0 094.39FALSE00
2026-09-18400PUT0 056.49FALSE00
2026-09-18434PUT0 157.14FALSE00
2026-09-18440PUT0 061.9FALSE00
2026-09-18450PUT0 061.77FALSE00
2026-09-18460PUT0 054.41FALSE00
2026-09-18475.5PUT0 157.13FALSE00
2026-09-18480PUT0 054.97FALSE00
2026-09-18490PUT0 055.19FALSE00
2026-09-18500PUT0 054.58FALSE00
2026-09-18550PUT0 056.06TRUE00
2026-09-18600PUT0 054.77TRUE00
2026-09-18650PUT0 052.64TRUE00
2026-09-18700PUT0 051.82TRUE00
2026-09-18750PUT0 053.46TRUE00
2026-12-18250CALL0 062.39TRUE00
2026-12-18280CALL0 061.75TRUE00
2026-12-18300CALL0 059.28TRUE00
2026-12-18330CALL0 056.73TRUE00
2026-12-18350CALL0 056.33TRUE00
2026-12-18380CALL0 054.76TRUE00
2026-12-184015.7CALL0 5255.18TRUE00
2026-12-18430CALL0 053.91TRUE00
2026-12-184512.5CALL0 2053.48TRUE00
2026-12-18478.6CALL0 1553.59TRUE00
2026-12-18500CALL0 053.44TRUE00
2026-12-18557.08CALL0 1052.06FALSE00
2026-12-18606CALL0 947.34FALSE00
2026-12-18650CALL0 050.09FALSE00
2026-12-18700CALL0 050.1FALSE00
2026-12-18750CALL0 049.65FALSE00
2026-12-18800CALL0 048.56FALSE00
2026-12-18250PUT0 0120.82FALSE00
2026-12-18280PUT0 0107.22FALSE00
2026-12-18300PUT0 099.1FALSE00
2026-12-18330PUT0 087.99FALSE00
2026-12-18350PUT0 081.18FALSE00
2026-12-18382.2PUT0 351.87FALSE00
2026-12-18400PUT0 051.19FALSE00
2026-12-18430PUT0 051.04FALSE00
2026-12-18454.4PUT0 151.89FALSE00
2026-12-18477.4PUT0 12250.67FALSE00
2026-12-18508.68PUT0 8851.04FALSE00
2026-12-185511.8PUT0 18750.02TRUE00
2026-12-18600PUT0 050.67TRUE00
2026-12-18650PUT0 050.57TRUE00
2026-12-18700PUT0 049.65TRUE00
2026-12-18750PUT0 049.45TRUE00
2026-12-18800PUT0 050.94TRUE00
2027-01-15250CALL0 063.37TRUE00
2027-01-15280CALL0 061.8TRUE00
2027-01-15300CALL0 059.08TRUE00
2027-01-15330CALL0 056.19TRUE00
2027-01-15350CALL0 4154.62TRUE00
2027-01-15380CALL0 053.8TRUE00
2027-01-15400CALL0 052.23TRUE00
2027-01-15430CALL0 051.07TRUE00
2027-01-15450CALL0 052.25TRUE00
2027-01-15470CALL0 052.3TRUE00
2027-01-155010CALL0 152.1TRUE00
2027-01-15550CALL0 051.77FALSE00
2027-01-15600CALL0 150.72FALSE00
2027-01-15650CALL0 050.15FALSE00
2027-01-15700CALL0 050.53FALSE00
2027-01-15250PUT0 0115.78FALSE00
2027-01-15280PUT0 0102.77FALSE00
2027-01-15300PUT0 095FALSE00
2027-01-15330PUT0 084.38FALSE00
2027-01-15350PUT0 077.87FALSE00
2027-01-15380PUT0 050.22FALSE00
2027-01-15400PUT0 052.33FALSE00
2027-01-15430PUT0 051.67FALSE00
2027-01-15450PUT0 050.48FALSE00
2027-01-15470PUT0 151.04FALSE00
2027-01-15500PUT0 049.92FALSE00
2027-01-15550PUT0 050.22TRUE00
2027-01-15600PUT0 149.34TRUE00
2027-01-15650PUT0 5449.04TRUE00
2027-01-15700PUT0 148.24TRUE00

Latest SUPN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$26.54
Jun 13, 2022 7:59 PM EST78$26.52
Jun 13, 2022 7:59 PM EST12$26.53
Jun 13, 2022 7:59 PM EST100$26.52
Jun 13, 2022 7:59 PM EST113$26.54

Supernus Pharmaceuticals, Inc (SUPN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm
2018-09-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018029835/0000000000-18-029835-index.htm
2018-11-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018034262/0000000000-18-034262-index.htm
2018-12-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018037479/0000000000-18-037479-index.htm
2019-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000019011207/0000000000-19-011207-index.htm
2019-08-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000019012145/0000000000-19-012145-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000021545719007287/0000215457-19-007287-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000083423720008681/0000834237-20-008681-index.htm
2020-03-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000091957420002390/0000919574-20-002390-index.htm
2019-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000093247119001355/0000932471-19-001355-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1356576/000104746919000828/0001047469-19-000828-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1356576/000104746919002684/0001047469-19-002684-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918032082/0001104659-18-032082-index.htm
2018-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918032502/0001104659-18-032502-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918034093/0001104659-18-034093-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918037201/0001104659-18-037201-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918039860/0001104659-18-039860-index.htm
2018-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2018-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043589/0001104659-18-043589-index.htm
2018-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043595/0001104659-18-043595-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043597/0001104659-18-043597-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2018-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918047769/0001104659-18-047769-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918050207/0001104659-18-050207-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918050920/0001104659-18-050920-index.htm
2018-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918055089/0001104659-18-055089-index.htm
2018-09-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918055660/0001104659-18-055660-index.htm
2018-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918057416/0001104659-18-057416-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918057845/0001104659-18-057845-index.htm
2018-10-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465918060747/0001104659-18-060747-index.htm
2018-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918063964/0001104659-18-063964-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918066367/0001104659-18-066367-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918066998/0001104659-18-066998-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918067217/0001104659-18-067217-index.htm
2018-11-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465918069011/0001104659-18-069011-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918072139/0001104659-18-072139-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918073844/0001104659-18-073844-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918074466/0001104659-18-074466-index.htm
2019-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919002327/0001104659-19-002327-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919005844/0001104659-19-005844-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919007979/0001104659-19-007979-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010743/0001104659-19-010743-index.htm
2019-02-265Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010791/0001104659-19-010791-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010794/0001104659-19-010794-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010795/0001104659-19-010795-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010796/0001104659-19-010796-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010797/0001104659-19-010797-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010798/0001104659-19-010798-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010799/0001104659-19-010799-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010800/0001104659-19-010800-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010801/0001104659-19-010801-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010802/0001104659-19-010802-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2019-03-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919012549/0001104659-19-012549-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919013142/0001104659-19-013142-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919016356/0001104659-19-016356-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919018296/0001104659-19-018296-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919019961/0001104659-19-019961-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919023424/0001104659-19-023424-index.htm
2019-04-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1356576/000110465919023500/0001104659-19-023500-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919027555/0001104659-19-027555-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465919028593/0001104659-19-028593-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919033130/0001104659-19-033130-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm
2019-07-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465919043062/0001104659-19-043062-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919043393/0001104659-19-043393-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919076466/0001104659-19-076466-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920017388/0001104659-20-017388-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024847/0001104659-20-024847-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024848/0001104659-20-024848-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024849/0001104659-20-024849-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024850/0001104659-20-024850-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024913/0001104659-20-024913-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024915/0001104659-20-024915-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024919/0001104659-20-024919-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024920/0001104659-20-024920-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465920026188/0001104659-20-026188-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920037450/0001104659-20-037450-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920050721/0001104659-20-050721-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1356576/000110465920050722/0001104659-20-050722-index.htm
2020-05-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1356576/000110465920056047/0001104659-20-056047-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920077403/0001104659-20-077403-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm
2020-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920100179/0001104659-20-100179-index.htm
2020-10-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920114365/0001104659-20-114365-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920114367/0001104659-20-114367-index.htm
2020-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000010/0001356576-19-000010-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000015/0001356576-19-000015-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000019/0001356576-19-000019-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657619000025/0001356576-19-000025-index.htm
2019-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000030/0001356576-19-000030-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000033/0001356576-19-000033-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000041/0001356576-19-000041-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000043/0001356576-19-000043-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657619000045/0001356576-19-000045-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000047/0001356576-19-000047-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000049/0001356576-19-000049-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000002/0001356576-20-000002-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000004/0001356576-20-000004-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000006/0001356576-20-000006-index.htm
2020-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000010/0001356576-20-000010-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000015/0001356576-20-000015-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000018/0001356576-20-000018-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000020/0001356576-20-000020-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000023/0001356576-20-000023-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000025/0001356576-20-000025-index.htm
2020-05-12NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000029/0001356576-20-000029-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000031/0001356576-20-000031-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000033/0001356576-20-000033-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000035/0001356576-20-000035-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000037/0001356576-20-000037-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000041/0001356576-20-000041-index.htm
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm
2020-08-11NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000048/0001356576-20-000048-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000050/0001356576-20-000050-index.htm
2020-08-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000054/0001356576-20-000054-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000056/0001356576-20-000056-index.htm
2020-08-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000059/0001356576-20-000059-index.htm
2020-09-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000062/0001356576-20-000062-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000064/0001356576-20-000064-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000066/0001356576-20-000066-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000068/0001356576-20-000068-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000070/0001356576-20-000070-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000072/0001356576-20-000072-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000076/0001356576-20-000076-index.htm
2018-11-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1356576/999999999718009168/9999999997-18-009168-index.htm

Supernus Pharmaceuticals, Inc (SUPN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Supernus Pharmaceuticals, Inc (SUPN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 361%
Institutional Ownership: 10146%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-06-29Padmanabh P. BhattSr. VP of IP, CSOSell4,393.0059.90263,153.000.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2020-02-21Frederick M. HudsonDirectorBuy5,211.0023.99125,011.8910,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm
2018-05-10Padmanabh P. BhattSr. VP of IP, CSOSell20,000.0049.88997,544.0012,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell20,000.0052.031,040,558.0012,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-06-21Padmanabh P. BhattSr. VP of IP, CSOBuy7,205.009.1365,781.6514,705.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOBuy7,500.009.1368,475.0015,000.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2020-07-13Frederick M. HudsonDirectorSell920.0024.4422,484.8018,041.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy10,882.009.24100,549.6818,382.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2020-07-13Frederick M. HudsonDirectorBuy8,750.002.5622,400.0018,961.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOSell60,000.0054.393,263,352.001,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOBuy20,000.007.90158,000.0021,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy11,250.009.24103,950.0023,750.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-08-20JOHN M SIEBERTDirectorBuy8,722.007.9068,903.8028,285.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2018-05-10Padmanabh P. BhattSr. VP of IP, CSOBuy20,000.007.90158,000.0032,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy20,000.007.90158,000.0032,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-08-20JOHN M SIEBERTDirectorBuy7,457.009.2468,902.6835,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2018-06-28Padmanabh P. BhattSr. VP of IP, CSOSell3,402.0059.94203,899.214,393.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2020-10-15GREGORY S PATRICKSr. VP, CFOSell15,000.0020.03300,507.0044,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-11-05GREGORY S PATRICKSr. VP, CFOSell5,000.0023.00115,000.0044,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2019-04-25JOHN M SIEBERTDirectorBuy10,000.009.1391,300.0045,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm
2020-05-08GREGORY S PATRICKSr VP, Chief Financial OfficerSell15,000.0023.14347,034.0046,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-20GREGORY S PATRICKSr.VP, Chief Financial OfficerSell15,000.0025.03375,379.5046,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2019-08-23Jack A. KhattarPresident, CEOBuy7,200.0026.39189,982.08465,141.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm
2019-02-27GREGORY S PATRICKSr VP, Chief Financial OfficerSell20,000.0041.53830,650.0047,896.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2020-07-10Jack A. KhattarPresident, CEOBuy15,625.00490,841.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm
2020-11-05GREGORY S PATRICKSr. VP, CFOBuy5,000.0012.9864,900.0049,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2020-07-27Jack A. KhattarPresident, CEOBuy15,625.00506,466.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm
2020-02-21Carrolee BarlowDirectorBuy5,211.0023.99125,011.895,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm
2020-02-21GEORGES GEMAYELDirectorBuy5,211.0023.99125,011.895,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm
2019-06-20JOHN M SIEBERTDirectorBuy10,000.009.1391,300.0055,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerSell35,000.0056.631,981,913.5055,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2020-10-15GREGORY S PATRICKSr. VP, CFOBuy15,000.0012.98194,700.0059,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-02-21JOHN M SIEBERTDirectorBuy5,211.0023.99125,011.8960,953.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm
2020-05-08GREGORY S PATRICKSr VP, Chief Financial OfficerBuy15,000.009.13136,950.0061,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-20GREGORY S PATRICKSr.VP, Chief Financial OfficerBuy15,000.0012.98194,700.0061,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOBuy40,000.009.24369,600.0061,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2019-02-27GREGORY S PATRICKSr VP, Chief Financial OfficerBuy20,000.009.13182,600.0067,896.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell16,250.0055.23897,542.757,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell10,882.0057.90630,067.807,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOSell368.0057.9321,316.627,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-06-21Padmanabh P. BhattSr. VP of IP, CSOSell7,205.0060.00432,323.067,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerBuy20,000.009.24184,800.0075,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2018-06-28Padmanabh P. BhattSr. VP of IP, CSOBuy295.009.132,693.357,795.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOBuy368.009.243,400.327,868.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerBuy15,000.009.13136,950.0090,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2020-02-21CHARLES W III NEWHALLDirectorBuy5,211.0023.99125,011.8997,509.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm